Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer

NCT00100945 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: gefitinib

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]